Cas 1133749-25-3,(R)-(3-methyl-4-(1-phenylpyrido[3,4-d]pyridazin-4-yl)piperazin-1-yl)(morpholino)methanone

1133749-25-3

Post Buying Request

Basic information

Product Name: (R)-(3-methyl-4-(1-phenylpyrido[3,4-d]pyridazin-4-yl)piperazin-1-yl)(morpholino)methanone
Synonyms: (R)-(3-methyl-4-(1-phenylpyrido[3,4-d]pyridazin-4-yl)piperazin-1-yl)(morpholino)methanone
CAS NO:1133749-25-3
Molecular Formula:
Molecular Weight: 418.498
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (R)-(3-methyl-4-(1-phenylpyrido[3,4-d]pyridazin-4-yl)piperazin-1-yl)(morpholino)methanone(CAS DataBase Reference)
NIST Chemistry Reference: (R)-(3-methyl-4-(1-phenylpyrido[3,4-d]pyridazin-4-yl)piperazin-1-yl)(morpholino)methanone(1133749-25-3)
EPA Substance Registry System: (R)-(3-methyl-4-(1-phenylpyrido[3,4-d]pyridazin-4-yl)piperazin-1-yl)(morpholino)methanone(1133749-25-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1133749-25-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1133749-25-3 Suppliers

Recommended suppliers

1133749-25-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1133749-25-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,3,3,7,4 and 9 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1133749-25:
(9*1)+(8*1)+(7*3)+(6*3)+(5*7)+(4*4)+(3*9)+(2*2)+(1*5)=143
143 % 10 = 3
So 1133749-25-3 is a valid CAS Registry Number.

1133749-25-3Upstream product

1133749-25-3Downstream Products

1133749-25-3Relevant academic research and scientific papers

ANNELATED PYRIDAZINES FOR THE TREATMENT OF TUMORS DRIVEN BY INAPPROPRIATE HEDGEHOG SIGNALLING

-

Page/Page column 56-57, (2009/04/25)

The present invention relates generally to compounds represented in Formula (I), pharmaceutical compositions comprising them and methods of treating of diseases or disorders such as cancer.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1133749-25-3